Dr. Azizul Haque is a distinguished Health Research Scientist at the Ralph Johnson VA Medical Center and Professor of Pharmacology and Immunology, and Neurosurgery at the Medical University of South Carolina (MUSC). Additionally, he holds a prestigious position as a Member of the Hollings Cancer Center at MUSC, where he contributes to cutting-edge research in inflammation, immunity, neurodegeneration, and cancer immunology. Recognized as a leading expert in his field, Dr. Haque is frequently sought after by prominent funding and regulatory agencies, including the National Institutes of Health (NIH), Department of Defense (DoD), and Department of Health and Human Services, to serve on grant and contract review panels. His insights help shape the future of biomedical research funding. An active contributor to the scientific community, Dr. Haque serves as a peer reviewer for high-impact journals and holds editorial roles in a number of journals. Dr. Haque’s pioneering research is supported by major funding bodies, including the NIH/NCI/NINDS, VA, and DoD. His work has led to dozens of peer-reviewed publications, cementing his reputation as a key figure in understanding immune mechanisms, neurodegenerative diseases, and cancer immunology. With a career dedicated to scientific discovery, mentorship, and collaboration, Dr. Haque continues to drive innovation in biomedical research, translating laboratory findings into potential therapeutic breakthroughs for human health.